Genzyme Recalls Transplant Drug

Genzyme Corporation has voluntarily recalled three lots of Thymoglobulin, a drug used in renal transplants. No other information about safety issues or potential adverse effects was available at the time the company released the recall news. The FDA has instructed Thymoglobulin customers to discontinue use of the affected lots and return them to Genzyme. The following information about the affected vials was posted on the FDA website:
Anti-thymocyte Globulin (Rabbit) 25 mg/vial
NDC # 58468-0080-1
Lot Numbers: C7014C01 (Expires May 31, 2010)
C7008C01 (Expires March 31, 2010)
TH175-05 (Expires October 4, 2009)
The transplant drug has been recalled because the drug was found to have a different appearance when it was reconstituted into solution form.